{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:53:20Z","timestamp":1792522400174,"version":"4.5.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the association between peripheral blood inflammatory biomarkers and the clinical phenotypes, severity, and prognosis of myasthenia gravis (MG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study analyzed 134 MG patients (including 23 with myasthenic crisis [MC]) and 58 age- and sex-matched healthy controls hospitalized at the Second Affiliated Hospital of Soochow University (August 2016\u2013March 2024). Peripheral blood inflammatory markers were compared across subgroups. Infection was strictly excluded based on clinical and laboratory criteria. Multivariate logistic regression and receiver operating characteristic (ROC) curve analyses were performed to identify risk factors and diagnostic value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to controls, MG patients exhibited significantly elevated neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI) (all\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). Patients with MC were characterized by a higher prevalence of generalized MG (GMG) and thymoma, as well as elevated leukocyte counts, NLR, and SIRI compared to non-MC patients. Multivariate analysis identified elevated PLR [OR: 1.01, 95% CI: 1.00\u20131.02] as independent risk factors associated with MG onset, while elevated NLR [OR: 1.20, 95% CI: 1.05\u20131.41] and the presence of thymoma [OR: 13.44, 95% CI: 4.42\u201348.54] were independently associated with MC. Furthermore, inflammatory indices (NLR, PLR, and SII) were significantly higher in GMG and moderate-to-severe cases (MGFA III\u2013V) compared to ocular and mild cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Systemic inflammatory biomarkers, particularly PLR and NLR, are significantly elevated in MG and correlate with disease severity and clinical subtypes. While PLR is associated with MG onset, NLR and thymoma are potential indicators for myasthenic crisis. These readily available markers may facilitate risk stratification in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1673022","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T05:22:49Z","timestamp":1770096169000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Inflammatory biomarker panels in peripheral blood: association with myasthenia gravis onset and severity"],"prefix":"10.3389","volume":"17","author":[{"given":"Hong","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunya","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmiao","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-feng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/cells8070671","article-title":"Myasthenia gravis: pathogenic effects of autoantibodies on neuromuscular architecture","volume":"8","author":"Koneczny","year":"2019","journal-title":"Cells"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mus.27832","article-title":"Myasthenic crisis","volume":"68","author":"Claytor","year":"2023","journal-title":"Muscle Nerve"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1336823","DOI":"10.3389\/fneur.2023.1336823","article-title":"High indirect bilirubin levels as an independent predictor of postoperative myasthenic crisis: a single-center, retrospective study","volume":"14","author":"Sun","year":"2023","journal-title":"Front Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molimm.2021.02.011","article-title":"Imbalance of Th17 and Tregs in thymoma may be a pathological mechanism of myasthenia gravis","volume":"133","author":"Chen","year":"2021","journal-title":"Mol Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.14336\/AD.2020.0410","article-title":"The role of immune cells in the pathogenesis of idiopathic inflammatory myopathies","volume":"12","author":"Zhao","year":"2021","journal-title":"Aging Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/acn3.51706","article-title":"The systemic inflammation markers as possible indices for predicting respiratory failure and outcome in patients with myasthenia gravis","volume":"10","author":"Huang","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5606\/tgkdc.dergisi.2023.24588","article-title":"The change of systemic inflammation response index in the treatment of patients with myasthenia gravis undergoing thymectomy: a retrospective, follow-up study","volume":"31","author":"Ulug\u00fcn","year":"2023","journal-title":"Turk Gogus Kalp Damar Cerrahisi Derg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.3390\/cells11162554","article-title":"The usefulness of extended inflammation parameters and systemic inflammatory response markers in the diagnostics of autoimmune hepatitis","volume":"11","author":"Domerecka","year":"2022","journal-title":"Cells"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.2147\/JIR.S449324","article-title":"Systemic inflammatory response index, a potential inflammatory biomarker in disease severity of myasthenia gravis: a pilot retrospective study","volume":"17","author":"Huang","year":"2024","journal-title":"J Inflamm Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser","year":"2021","journal-title":"J Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3233\/JND-150082","article-title":"Psychometric properties of the quantitative myasthenia gravis score and the myasthenia gravis composite scale","volume":"2","author":"Barnett","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/ane.13549","article-title":"Comorbidities in older patients with myasthenia gravis \u2013 comparison between early- and late-onset disease","volume":"145","author":"Klimiec-Moskal","year":"2022","journal-title":"Acta Neurol Scand"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12974-022-02448-4","article-title":"Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients","volume":"19","author":"Nelke","year":"2022","journal-title":"J Neuroinflammation"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40259-024-00701-1","article-title":"New and emerging biological therapies for myasthenia gravis: a focussed review for clinical decision-making","volume":"39","author":"Gerischer","year":"2025","journal-title":"BioDrugs"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"619705","DOI":"10.3389\/fimmu.2020.619705","article-title":"Role of neutrophils in systemic vasculitides","volume":"11","author":"Michailidou","year":"2020","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"614829","DOI":"10.3389\/fmed.2021.614829","article-title":"Neutrophil extracellular traps in the autoimmunity context","volume":"8","author":"Bruschi","year":"2021","journal-title":"Front Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"103395","DOI":"10.1016\/j.jaut.2025.103395","article-title":"Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis","volume":"152","author":"Zhang","year":"2025","journal-title":"J Autoimmun"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"eaao3089","DOI":"10.1126\/scitranslmed.aao3089","article-title":"Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis","volume":"10","author":"Maugeri","year":"2018","journal-title":"Sci Transl Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s13760-024-02693-9","article-title":"Ocular myasthenia gravis: determining the predictive factors of secondary generalisation","volume":"125","author":"Gengadharan","year":"2025","journal-title":"Acta Neurol Belg"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3389\/fimmu.2020.00664","article-title":"Thymoma associated myasthenia gravis (TAMG): differential expression of functional pathways in relation to MG status in different thymoma Histotypes","volume":"11","author":"Yamada","year":"2020","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevImmunol.2024051413","article-title":"The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis","volume":"44","author":"Zhou","year":"2024","journal-title":"Crit Rev Immunol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/ijms19030730","article-title":"The balance of Th17 versus Treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1673022\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:30:14Z","timestamp":1771925414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1673022\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":22,"alternative-id":["10.3389\/fneur.2026.1673022"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1673022","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"article-number":"1673022"}}